Application no. and date | 14809570.6 (espacenet) (Federated) (European Patent Register), 20141121 | Patent/reg. no. and date | DK/EP 2897589, 20180103 | Publication date | 20150729 | Priority no. and date | US 201361907778 P, 20131122 | EP pub. no. and date |
EP 2897589 20150729 | Effective date | | Applicant/owner | Teva Branded Pharmaceutical Products R & D, Inc., 41 Moores Road
Frazer, PA 19355, US | Applicant ref. no. | P81800776DK00E | Inventor | WU, Libo, 74 NW 176th Street
Miami, FL 33169, US, DALVI, Mukul, 74 NW 176th Street
Miami, FL 33169, US | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | Opponent | | IPC Class | A61K 31/46 (2006.01) , A61K 47/02 (2006.01) , A61K 47/06 (2006.01) , A61K 47/10 (2017.01) , A61K 47/12 (2006.01) , A61K 9/00 (2006.01) , A61K 9/08 (2006.01) , A61M 11/00 (2006.01) , A61M 15/00 (2006.01) | Title | Medikament, der kan inhaleres | Int. application no. | US2014066840 | Int. publication no. | WO2015077574 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|